Approval of esketamine for treatment-resistant depression – Authors' reply
Author:
Publisher
Elsevier BV
Subject
Biological Psychiatry,Psychiatry and Mental health
Reference7 articles.
1. Approval of esketamine for treatment-resistant depression;Singh;Lancet Psychiatry,2020
2. The clinical relevance of changes in the Montgomery-Asberg Depression Rating Scale using the minimum clinically important difference approach;Duru;Curr Med Res Opin,2008
3. What does the MADRS mean? Equipercentile linking with the CGI using a company database of mirtazapine studies;Leucht;J Affect Disord,2017
4. Efficacy and safety of fixed-dose esketamine nasal spray combined with a new oral antidepressant in treatment-resistant depression: results of a randomized, double-blind, active-controlled study (TRANSFORM-1);Fedgchin;Int J Neuropsychopharmacol,2019
5. Efficacy and safety of flexibly dosed esketamine nasal spray combined with a newly initiated oral antidepressant in treatment-resistant depression: a randomized double-blind active-controlled study;Popova;Am J Psychiatry,2019
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Safety and Tolerability of the Acute Ketamine Treatment in Treatment-Resistant Depression: Focus on Comorbidities Interplay with Dissociation and Psychomimetic Symptoms;Pharmaceuticals;2023-01-24
2. Safety concerns on the abuse potential of esketamine: Multidimensional analysis of a new anti‐depressive drug on the market;Fundamental & Clinical Pharmacology;2021-12-23
3. Post-Marketing Safety Concerns with Esketamine: A Disproportionality Analysis of Spontaneous Reports Submitted to the FDA Adverse Event Reporting System;Psychotherapy and Psychosomatics;2020-08-27
4. Orphan G Protein Coupled Receptors in Affective Disorders;Genes;2020-06-24
5. Esketamine clinical trials: reply to Maju et al.;Epidemiology and Psychiatric Sciences;2020
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3